Tarsa Therapeutics raises capital for osteoporosis drug that’s in NDA screening
The once-per-day pill, called TBRIA, which has shown better bone reabsorption rates than controls in clinical study.
The once-per-day pill, called TBRIA, which has shown better bone reabsorption rates than controls in clinical study.